CRISPR THERAPEUTICS AG revenue breakdown overview

CRISPR THERAPEUTICS AG revenue for the last year amounted to 6.30 B MXN, the most of which — 6.28 B MXN — came from its highest performing source at the moment, Collaboration, the year earlier bringing 8.50 M MXN. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR THERAPEUTICS AG 6.30 B MXN, and the year before that — 23.37 M MXN.